Skip to main content
. 2023 Aug 7;21:292. doi: 10.1186/s12916-023-03000-8

Table 1.

General characteristics and incidence of congenital malformations between women with and without folic acid supplementation

General characteristics and congenital malformations Folic acid supplementation
Yes (N = 15,848) No (N = 887) Total (N = 16,735) P value
Region 0.32
 East 7900 (49.8) 442 (49.8) 8345
 West 4084 (25.8) 210 (23.7) 4301
 North 2974 (18.8) 176 (19.8) 3150
 Central 890 (5.6) 59 (6.7) 949
Han ethnicity 15,119 (95.4) 845 (95.3) 15,964 (95.4) 0.67
Education level (years)  < 0.001
  < 9 1426 (9.0) 137 (15.4) 1563 (9.3)
 10–12 2157 (13.6) 157 (17.7) 2314 (13.8)
 13–15 4044 (25.5) 241 (27.2) 4285 (25.6)
  ≥ 16 8221 (51.9) 352 (39.7) 8573 (51.2)
Family income (RMB Yuan per person per month)a 0.043
  < 3000 537 (3.4) 35 (3.9) 572 (3.4)
 3000–5000 4936 (31.1) 308 (34.7) 5244 (31.3)
 5001–8000 5149 (32.5) 284 (32.0) 5433 (32.5)
  > 8000 4770 (30.1) 230 (25.9) 5000 (29.9)
History of adverse pregnant outcomesb 2884 (18.2) 129 (14.5) 3013 (18.0) 0.006
Early-pregnant conditionsc 6169 (38.9) 308 (34.7) 6477 (38.7) 0.012
Natural conception 14,649 (92.4) 862 (97.2) 15,511 (92.7)  < 0.001
Periconceptional medicine exposure 4221 (26.6) 194 (21.9) 4415 (26.4) 0.002
Nulliparous women 10,812 (68.2) 441 (49.7) 11,253 (67.2)  < 0.001
Maternal age (years) 0.001
  < 25 1527 (9.6) 109 (12.3) 1636 (9.8)
 25–34 12,679 (80.0) 663 (74.7) 13,342 (79.7)
  ≥ 35 1642 (10.4) 115 (13.0) 1757 (10.5)
Congenital malformations
 Total, no. (%) 252 (1.6) 21 (2.4) 273 (1.6) 0.075
 Heart defects, no. (per 1000 infants) 60 (3.8) 7 (7.9) 67 (4.0) 0.089
 Neural tube defects, no. (per 10,000 infants) 11 (6.9) 1 (11.3) 12 (7.2) 0.47

aInformation of family income was not available for 486 women

bAdverse pregnancy outcomes refer to abortion, ectopic pregnancy, infertility, induced labour, congenital malformations, or preterm birth in previous pregnancies

cEarly pregnancy conditions mean influenza/cold, a fever ≥ 38℃, skin rash, vaginal bleeding, thyroid dysfunction, gestational hyperglycemia/diabetes, gastrointestinal diseases, gynaecological inflammation or diseases